Reidispongiolide A is a representative member of the sphinxolide͞ reidispongiolide group of cytotoxic 26-membered macrolides of marine origin. By interacting with actin in the cell cytoskeleton, the reidispongiolides and sphinxolides are potent microfilament destabilizing agents that represent a promising mechanism of action for developing novel anticancer drugs. An aldol-based synthesis of a library of diastereomers of C 8 -C 16 and C 5 -C 16 fragments and detailed NMR comparison with a reported degradation fragment enabled a configurational assignment for a major part of the reidispongiolide macrocyclic core, thus setting a solid foundation for ongoing synthetic efforts.M arine macrolides provide a fascinating range of structural and functional diversity, which may find application inter alia as specific molecular probes for the investigation of the cytoskeleton and cell cycle events. Unique to eukaryotic cells, the actin cytoskeleton plays a critical role in the determination of cell shape, and in a variety of cellular processes, including cell motility, division, adhesion, and intracellular transportation (1). In comparison with microtubule-interacting agents (2), such as the taxanes and vinca alkaloids, the development of anticancer drugs based on selective binding to actin and disruption of microfilament assembly has attracted relatively little attention. However, recent insight into the role played by microfilaments in cell division and metastasis has highlighted the potential of certain structural classes of actin-binding natural products as useful leads for cancer chemotherapy (3).A growing family of actin-binding macrolides that disrupt microfilament organization includes the scytophycins (e.g., 1, Fig. 1), isolated from the blue-green algae Scytonema pseudohofmanni (4), aplyronines (e.g., 2), isolated from the sea hare Aplysia kurodai (5), and sphinxolides (e.g., 3, planar structure), first reported from an unidentified Pacific nudibranch (6) and later reisolated from the New Caledonian marine sponges Neosiphonia superstes and Reidispongia coreulea, along with the congeneric reidispongiolides (e.g., 4, planar structure) (7,8). A related family of trisoxazole-containing marine macrolides, typified by mycalolide A (5) and jaspisamide A (6), are also antimicrofilament agents (9). Recently, an x-ray crystal structure of the latter compound bound to actin (10) highlighted the importance of the characteristic N-vinyl formamide-containing side chain, common to all these macrolides, in determining their biological activity. Moreover, all these actin-binding macrolides inhibit the proliferation of human cancer cell lines; for example, the scytophycins and sphinxolides exhibit potent cytotoxicity against L1210 and KB cells, with IC 50 values ranging from ng͞ml to pg͞ml (9). In addition, aplyronine A shows potent antitumor activity in vivo and has potential as a clinical candidate (9). Notably, both the scytophycins and sphinxolides circumvent multidrug resistance mediated by the overexpression of P-glycoprotein...